Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Structure of Cardiac Muscles

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

In vitro antimicrobial and antibiofilm screening of eighteen Iranian medicinal plants.

BMC complementary medicine and therapies·2024

Same author

Maternal Vertical Microbial Transmission During Skin-to-Skin Care.

Advances in neonatal care : official journal of the National Association of Neonatal Nurses·2023

Same author

Maternal stress during the third trimester of pregnancy and the neonatal microbiome.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2023

Same author

Antimicrobial Stewardship Programs in Preterm Infants: Encouraging Staff Nurse Engagement.

Neonatal network : NN·2022

Same author

A National Survey of Neonatal Nurses' Knowledge, Beliefs, and Practices of Antibiotic Stewardship.

Advances in neonatal care : official journal of the National Association of Neonatal Nurses·2022

Same author

Distinct visual resolution supports aperture shaping in natural and pantomime-grasping.

Canadian journal of experimental psychology = Revue canadienne de psychologie experimentale·2021

Search research articles

Related Experiment Video

Updated: Jun 11, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Primary cardiac sarcoma.

Maryam Hamidi¹, John S Moody, Tracey L Weigel

¹Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin 53705, USA. hamidi@humonc.wisc.edu

The Annals of Thoracic Surgery

|July 9, 2010

Summary

This summary is machine-generated.

Primary cardiac sarcomas are rare, aggressive cancers with a poor prognosis, often presenting at advanced stages. Surgical intervention significantly improves survival, highlighting its critical role in management.

More Related Videos

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Related Experiment Videos

Last Updated: Jun 11, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Area of Science:

Cardiovascular Pathology
Oncology
Surgical Oncology

Background:

Primary cardiac sarcomas are rare and poorly understood, with undefined presentation, management, and outcomes.
The efficacy of adjuvant therapy in primary cardiac sarcoma management remains unclear.

Purpose of the Study:

To define the clinical characteristics and outcomes of primary cardiac sarcomas.
To compare primary cardiac sarcomas with noncardiac sarcomas using population-based data.
To identify prognostic factors for primary cardiac sarcoma survival.

Main Methods:

Utilized the Surveillance, Epidemiology, and End Results (SEER) database to identify patients diagnosed with primary cardiac sarcoma or noncardiac sarcoma between 1988 and 2005.
Conducted univariate and multivariate analyses to determine factors influencing survival in primary cardiac sarcoma patients.
Compared clinical features and survival rates between primary cardiac sarcoma and noncardiac sarcoma cohorts.

Main Results:

Primary cardiac sarcomas occurred in a younger demographic and presented more frequently with advanced disease compared to noncardiac sarcomas.
Vessel-derived sarcomas, such as angiosarcoma, constituted nearly half of primary cardiac sarcoma cases.
Median overall survival was significantly poorer for cardiac sarcoma patients (6 months) versus noncardiac sarcoma patients (93 months).
Surgery improved median survival for cardiac sarcoma patients to 12 months, compared to 1 month for non-surgical cases.

Conclusions:

Cardiac sarcomas represent a rare, distinct subtype of soft tissue sarcoma with a dismal prognosis.
Surgery is the cornerstone of effective management for cardiac sarcomas.
Future research should focus on enabling radical surgical excision and developing effective adjuvant therapies.